Transform specimen processing for COVID testing
No uncapping and no specimen transfer. Expedite your SARS-CoV-2* workflow with a collection device that loads directly on the Panther® system. The Direct Load Tube Collection Kit is authorized for use with the Aptima® SARS-CoV-2 and Aptima® SARS-CoV-2/Flu assays.
One-Step Workflow — Deliver Results Sooner
Traditional Respiratory Specimen Workflow
Reduce Labor, Costs and Risk with Fewer Steps
| |
|
|
|
 Eliminate manual uncapping and recapping
|
|
One collection kit for nasal and OP swabs
|
| |
|
|
|
Remove manual specimen transfer steps
|
|
Inactivates common respiratory viruses
|
| |
|
|
|
Reduce human error and repetitive motion injuries
|
|
Guanidine free, non-toxic media
|
| |
|
|
| Reduce costs for additional consumables |
|
Penetrable cap serves as additional cross-contamination barrier |
* The Aptima SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays have not been FDA cleared or approved; These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima SARS-CoV-2 assay has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, Flu A and Flu B and not for any other viruses or pathogens. The Aptima SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
